{"title":"病毒性肺炎的治疗进展","authors":"T. Suo, Hui Fan, Guo-zhong Chen","doi":"10.14188/J.1671-8852.2020.6018","DOIUrl":null,"url":null,"abstract":"A review As research has progressed, viral pathogens are increasingly recognized as a cause of pneumonia More than 20 viruses have been linked to community acquired pneumonia (CAP) Apart from the US Food and Drug Administration approved medications for treatment of influenza pneumonia, the treatment of noninfluenza respiratory viruses is limited In order to provide more theor basis for the clin treatment of viral pneumonia, this paper summarizes the related research progress of viral pneumonia treatment","PeriodicalId":35402,"journal":{"name":"武汉大学学报(医学版)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advances in the treatment of viral pneumonia\",\"authors\":\"T. Suo, Hui Fan, Guo-zhong Chen\",\"doi\":\"10.14188/J.1671-8852.2020.6018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A review As research has progressed, viral pathogens are increasingly recognized as a cause of pneumonia More than 20 viruses have been linked to community acquired pneumonia (CAP) Apart from the US Food and Drug Administration approved medications for treatment of influenza pneumonia, the treatment of noninfluenza respiratory viruses is limited In order to provide more theor basis for the clin treatment of viral pneumonia, this paper summarizes the related research progress of viral pneumonia treatment\",\"PeriodicalId\":35402,\"journal\":{\"name\":\"武汉大学学报(医学版)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"武汉大学学报(医学版)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.14188/J.1671-8852.2020.6018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"武汉大学学报(医学版)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.14188/J.1671-8852.2020.6018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
A review As research has progressed, viral pathogens are increasingly recognized as a cause of pneumonia More than 20 viruses have been linked to community acquired pneumonia (CAP) Apart from the US Food and Drug Administration approved medications for treatment of influenza pneumonia, the treatment of noninfluenza respiratory viruses is limited In order to provide more theor basis for the clin treatment of viral pneumonia, this paper summarizes the related research progress of viral pneumonia treatment
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
